COMBINED CYTOLOGY AND MOLECULAR TESTING FOR EARLY DETECTION OF ESOPHAGEAL ADENOCARCINOMA

摘要

The present invention provides methods, devices, and kits to determine a patient's risk of developing esophageal adenocarcinoma (EAC) and for early detection of EAC. In particular, the invention provides methods useful for determining whether a subject is at risk of EAC by, e.g., determining a change in one or more biomarkers in a biological sample obtained from the esophagus of the subject.